http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102114842-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1825 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-64 |
| filingDate | 2017-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102114842-B1 |
| titleOfInvention | Topical Formulation Composed of Cell Permeable basic Fibroblast Growth Factor (LMWP-bFGF) fusion protein with Skin Physiological Activity |
| abstract | The present invention relates to a composition for external application for skin containing a cell-permeable fibroblast growth factor fusion protein, and has excellent cell permeability of the bio-active material contained in the protein without being toxic to skin cells, thereby improving skin (recovering) and anti-aging. Or it can be used particularly effectively for wound healing. In addition, the cell-permeable fusion protein according to the present invention further comprises 1,2-hexanediol (Hexanediol), thereby exhibiting a remarkable synergistic effect in promoting collagen production, and thus can be more effectively used for anti-aging or wound healing. |
| priorityDate | 2016-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 191.